Testing vaccines and biologics against dangerous infectious diseases in primates
Task V02: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates
['FUNDING_OTHER'] · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · NIH-10712849
This study is testing new vaccines to see if they are safe and work well against serious infections, like the Nipah virus, so that one day, people can have better protection against these diseases.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BATTELLE CENTERS/PUB HLTH RES & EVALUATN (nih funded) |
| Locations | 1 site (COLUMBUS, UNITED STATES) |
| Trial ID | NIH-10712849 on ClinicalTrials.gov |
What this research studies
This research focuses on evaluating the safety and effectiveness of new vaccines and biologics designed to combat serious infectious diseases. Using non-human primates, the study conducts feasibility assessments and prepares necessary documentation for regulatory approval of these medical countermeasures. Patients may benefit from the eventual development of vaccines that could protect against severe diseases like Nipah virus. The research aims to ensure that new treatments are both safe and effective before they are made available to the public.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals at risk of exposure to BSL-4 pathogens or those in need of new vaccine options for serious infectious diseases.
Not a fit: Patients who are not at risk for BSL-4 pathogens or who have existing effective vaccines may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines against highly infectious and dangerous diseases.
How similar studies have performed: Other research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising approach.
Where this research is happening
COLUMBUS, UNITED STATES
- BATTELLE CENTERS/PUB HLTH RES & EVALUATN — COLUMBUS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RUDGE, THOMAS — BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- Study coordinator: RUDGE, THOMAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder